Hatem A. Elshabrawy, Ph.D.
Affiliations: | 2012 | Microbiology and Immunology | University of Illinois at Chicago, Chicago, IL, United States |
Area:
Virology BiologyGoogle:
"Hatem Elshabrawy"Parents
Sign in to add mentorBellur S. Prabhakar | grad student | 2012 | University of Illinois, Chicago | |
(Development of Instantaneous Protection against SARS-CoV with Implications for Multiple RNA Viruses.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Elshabrawy HA. (2020) SARS-CoV-2: An Update on Potential Antivirals in Light of SARS-CoV Antiviral Drug Discoveries. Vaccines. 8 |
Elshabrawy HA, Essani AE, Szekanecz Z, et al. (2016) TLRs, future potential therapeutic targets for RA. Autoimmunity Reviews |
Haddad CS, Bhattacharya P, Alharshawi K, et al. (2016) Age-dependent divergent effects of OX40L treatment on the development of diabetes in NOD mice. Autoimmunity. 1-14 |
Bhattacharya P, Thiruppathi M, Elshabrawy HA, et al. (2015) GM-CSF: An immune modulatory cytokine that can suppress autoimmunity. Cytokine. 75: 261-71 |
Elshabrawy HA, Erickson TB, Prabhakar BS. (2015) Ebola virus outbreak, updates on current therapeutic strategies. Reviews in Medical Virology. 25: 241-53 |
Lee HW, Khan SQ, Faridi MH, et al. (2015) A Podocyte-Based Automated Screening Assay Identifies Protective Small Molecules. Journal of the American Society of Nephrology : Jasn |
Bhattacharya P, Budnick I, Singh M, et al. (2015) Dual Role of GM-CSF as a Pro-Inflammatory and a Regulatory Cytokine: Implications for Immune Therapy. Journal of Interferon & Cytokine Research : the Official Journal of the International Society For Interferon and Cytokine Research |
Bhattacharya P, Thiruppathi M, Elshabrawy HA, et al. (2015) GM-CSF: An immune modulatory cytokine that can suppress autoimmunity Cytokine. 75: 261-271 |
Bhattacharya P, Fan J, Haddad C, et al. (2014) A novel pancreatic β-cell targeting bispecific-antibody (BsAb) can prevent the development of type 1 diabetes in NOD mice. Clinical Immunology (Orlando, Fla.). 153: 187-98 |
Elshabrawy HA, Fan J, Haddad CS, et al. (2014) Identification of a broad-spectrum antiviral small molecule against severe acute respiratory syndrome coronavirus and Ebola, Hendra, and Nipah viruses by using a novel high-throughput screening assay. Journal of Virology. 88: 4353-65 |